Prime

    Type your tag names separated by a space and hit enter

    Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement.

    Abstract

    DESCRIPTION

    New U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for chronic kidney disease (CKD).

    METHODS

    The USPSTF reviewed evidence on screening for CKD, including evidence on screening, accuracy of screening, early treatment, and harms of screening and early treatment.

    POPULATION

    This recommendation applies to asymptomatic adults without diagnosed CKD. Testing for and monitoring CKD for the purpose of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation.

    RECOMMENDATION

    The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of routine screening for CKD in asymptomatic adults (I statement).

    Links

  • Publisher Full Text

    • Grapherence [↓25]

    Authors

    Moyer VA
    ,
    U.S. Preventive Services Task Force

    Source

    Annals of internal medicine 157:8 2012 Oct 16 pg 567-70

    MeSH

    Adult
    Albuminuria
    Asymptomatic Diseases
    Cost of Illness
    Early Diagnosis
    Glomerular Filtration Rate
    Humans
    Renal Insufficiency, Chronic
    Risk Assessment

    Pub Type(s)

    Journal Article
    Practice Guideline
    Research Support, U.S. Gov't, P.H.S.

    Language

    eng

    PubMed ID

    22928170

    Citation

    TY - JOUR T1 - Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. AU - Moyer,Virginia A, AU - ,, PY - 2012/8/29/entrez PY - 2012/8/29/pubmed PY - 2013/1/15/medline SP - 567 EP - 70 JF - Annals of internal medicine JO - Ann. Intern. Med. VL - 157 IS - 8 N2 - DESCRIPTION: New U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for chronic kidney disease (CKD). METHODS: The USPSTF reviewed evidence on screening for CKD, including evidence on screening, accuracy of screening, early treatment, and harms of screening and early treatment. POPULATION: This recommendation applies to asymptomatic adults without diagnosed CKD. Testing for and monitoring CKD for the purpose of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation. RECOMMENDATION: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of routine screening for CKD in asymptomatic adults (I statement). SN - 1539-3704 UR - https://www.unboundmedicine.com/medline/citation/22928170/full_citation L2 - http://www.annals.org/article.aspx?volume=157&issue=8&page=567 ER -